Macroaxis considers Can Fite to be not too risky. Can Fite BioPharma
secures Sharpe Ratio (or Efficiency) of -0.0212 which signifies that Can Fite BioPharma
had -0.0212% of return per unit of risk over the last 1 month. Macroaxis philosophy towards foreseeing risk of any stock is to look at both systematic and un-systematic factors of the business, including all available market data and technical indicators
. Can Fite BioPharma Ltd exposes twenty-one different technical indicators
which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm Can Fite BioPharma Risk Adjusted Performance
of 0.18 and Mean Deviation of 1.21 to double-check risk estimate we provide. Macroaxis gives Can Fite performance score of 0 on a scale of 0 to 100. The firm shows Beta (market volatility) of -0.9932 which signifies that . Even though it is essential to pay attention to Can Fite BioPharma historical returns, it is always good to be careful when utilizing equity current trending patterns. Macroaxis philosophy towards foreseeing future performance of any stock is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Can Fite BioPharma Ltd exposes twenty-one different technical indicators which can help you to evaluate its performance. Can Fite BioPharma has expected return of -0.032%. Please be advised to confirm Can Fite BioPharma Standard Deviation, Information Ratio, Treynor Ratio, as well as the relationship between Variance and Jensen Alpha to decide if Can Fite BioPharma past performance will be repeated at some point in the near future.
|15 days auto-correlation|| 0.33 |
Below average predictability
Can Fite BioPharma Ltd has below average predictability. Overlapping area represents the amount of predictability between Can Fite time series from September 17, 2018 to October 2, 2018 and October 2, 2018 to October 17, 2018. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Can Fite BioPharma price movement. The serial correlation of 0.33 indicates that nearly 33.0% of current Can Fite price fluctuation can be explain by its past prices.
|Spearman Rank Test||0.17|